Skip to main content
Screener/Healthcare/Medical - Diagnostics & Research

WGS — GeneDx Holdings Corp.

NASDAQ
$98.39+3.91 (+4.13%)
Mid CapHealthcareHigh Beta
$32.21
$170.87
$94.23
$99.72
EPS (TTM)$-2.66
P/E Ratio-84.52
Dividend Yield—
Market Cap$2.56B
Volume233K
Prev Close$94.64
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$102.3M-$63.3M$-2.1666.7%-61.9%
Q4 '25$121.0M-$17.7M$-0.5965.2%-14.6%
Q3 '25$116.7M-$7.6M$-0.2772.4%-6.5%
Q2 '25$102.7M$10.8M$0.3669.0%10.5%
Q1 '25$87.1M-$6.5M$-0.2367.1%-7.5%
Q4 '24$95.6M$5.4M$0.2069.2%5.7%
Q3 '24$76.9M-$8.3M$-0.3162.2%-10.8%
Q2 '24$70.5M-$29.2M$-1.1060.9%-41.4%
Get Your Daily Market Recap